← Leaderboards
Kevin C O'Connor
Yale University
$6,561,949
Attributed
$6,907,886
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,907,886 · 9
By mechanism
R01$4,072,639 · 1
R21$2,028,937 · 5
R56$416,250 · 1
R03$244,756 · 1
U54$145,304 · 1
Top collaborators
- John F. Kveton1 shared
- Dhasakumar S Navaratnam1 shared
- Mary Tomayko1 shared
Most similar at Yale University
Same institution · by research overlap
- Joseph E Craft$42,575,841
- Mark J Shlomchik$51,286,869
- Akiko Iwasaki$25,435,081
- Lynne J. Regan$5,175,242
- Adam Wisnewski$9,947,944
Others in their field
Top investigators on “Autoantibodies”
- Jeffrey P Krischer · University Of South Florida$214,327,112
- Dorothy J Becker · Children'S Hosp Pittsburgh/Upmc Hlth Sys$36,769,044
- Marian J. Rewers · University Of Colorado Denver$35,235,150
- Russell E Ware · Duke University$33,922,841
- Betty Diamond · Feinstein Institute For Medical Research$31,327,232
- V Michael Holers · University Of Colorado Denver$25,425,841
Research focus
AutoantibodiesMediatingPathologyAntigensB-LymphocytesAutoimmune DiseasesAffectRecombinantsCellsImmunopathologyImmuneAutoimmunityNeuromuscular JunctionPathogenicityMolecularInvestigationAntibodiesMyasthenia GravisInsightDesignCholinergic ReceptorsProductionCharacteristicsClinical Trials
Grant awards (23)
Mechanisms of autoimmunity in myasthenia gravis$477,440
R01 · FY2025 · AI · contact PI
An Immunological investigation of Meniere's disease$461,250
R21 · FY2025 · DC
Mechanisms of autoimmunity in myasthenia gravis$335,000
R01 · FY2025 · AI · contact PI
Identifying new antigens in human autoantibody-mediated disease$251,375
R21 · FY2025 · AI · contact PI
Project 3$145,304
U54 · FY2025 · NS · contact PI
Defining the autoimmune mechanisms driving human MOG antibody disease pathology$209,375
R21 · FY2024 · AI · contact PI
Mechanisms of autoimmunity in myasthenia gravis$486,020
R01 · FY2023 · AI · contact PI
Defining the autoimmune mechanisms driving human MOG antibody disease pathology$251,250
R21 · FY2023 · AI · contact PI
Mechanisms of autoimmunity in myasthenia gravis$493,735
R01 · FY2022 · AI · contact PI
Molecular determinants driving diverse mechanisms of antibody-mediated pathology$209,375
R21 · FY2022 · AI · contact PI
Mechanisms of autoimmunity in myasthenia gravis$501,173
R01 · FY2021 · AI · contact PI
Molecular determinants driving diverse mechanisms of antibody-mediated pathology$251,250
R21 · FY2021 · AI · contact PI
Mechanisms of autoantibody production in myasthenia gravis$418,750
R01 · FY2020 · AI · contact PI
Novel Approaches for Investigating the Pathology of Myasthenia Gravis Autoantibodies$171,386
R21 · FY2020 · AI · contact PI
Mechanisms of autoantibody production in myasthenia gravis$418,750
R01 · FY2019 · AI · contact PI
Novel Approaches for Investigating the Pathology of Myasthenia Gravis Autoantibodies$223,676
R21 · FY2019 · AI · contact PI
Mechanisms of autoantibody production in myasthenia gravis$418,750
R01 · FY2018 · AI · contact PI
Mechanisms of autoantibody production in myasthenia gravis$418,750
R01 · FY2017 · AI · contact PI
Mechanisms of autoantibody production in myasthenia gravis$104,271
R01 · FY2016 · AI · contact PI
Mechanisms of autoantibody production in myasthenia gravis$416,250
R56 · FY2015 · AI · contact PI
Discovery of Novel Autoantigens in Patients with Inclusion Body Myositis$79,048
R03 · FY2013 · AR · contact PI
Discovery of novel autoantigens in patients with inclusion body myositis$82,958
R03 · FY2012 · AR · contact PI
Discovery of novel autoantigens in patients with inclusion body myositis$82,750
R03 · FY2011 · AR · contact PI